Details for New Drug Application (NDA): 206001
✉ Email this page to a colleague
NDA 206001 describes ATRACURIUM BESYLATE PRESERVATIVE FREE, which is a drug marketed by Baxter Hlthcare, Baxter Hlthcare Corp, Eugia Pharma, Hikma, Hospira, Hospira Inc, Meitheal, Norvium Bioscience, and Watson Labs Inc, and is included in eleven NDAs. It is available from three suppliers. Additional details are available on the ATRACURIUM BESYLATE PRESERVATIVE FREE profile page.
The generic ingredient in ATRACURIUM BESYLATE PRESERVATIVE FREE is atracurium besylate. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.
The generic ingredient in ATRACURIUM BESYLATE PRESERVATIVE FREE is atracurium besylate. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.
Summary for 206001
| Tradename: | ATRACURIUM BESYLATE PRESERVATIVE FREE |
| Applicant: | Norvium Bioscience |
| Ingredient: | atracurium besylate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 206001
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
| Approval Date: | Apr 7, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
